Clinical Lymphatic Mapping in Gynecologic Cancers

Charles Levenback

ISBN 10: 1032186437 / ISBN 13: 9781032186436

Published by Taylor & Francis Ltd Feb 2022, 2022

About this Item

Neuware - Lymphatic mapping techniques have proven to be useful to the early detection and safe treatment of endometrial and cervical cancers; however, the techniques have much of value to offer for breast cancer also and particularly for vulvar cancer, where there has been an explosion of interest and research.

Seller Inventory # 9781032186436

Bibliographic Details

• Title: Clinical Lymphatic Mapping in Gynecologic Cancers
• Publisher: Taylor & Francis Ltd Feb 2022
• Publication Date: 2022
• Language: English
• ISBN 10: 1032186437
• ISBN 13: 9781032186436
• Binding: Buch
• Edition: 2nd Edition
• Condition: Neu
• Dimensions: 280W x 210H x 0D millimeters 280 millimeters width by 210 millimeters height by 0 millimeters depth
• Weight: 450 grams

About this title

Synopsis

Lymphatic mapping techniques have proven to be useful to the early detection and safe treatment of endometrial and cervical cancers; however, the techniques have much of value to offer for breast cancer also and particularly for vulvar cancer, where there has been an explosion of interest and research. In the new edition of Clinical Lymphatic Mapping of Gynecologic Cancers, the techniques are fully explained, with consideration of the latest developments and technologies.

About the Author

Charles Levenback, MD is Professor and Deputy Chairman, Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA, and formerly Chief Professionalism Officer. In 2017 he shared the Society of Gynecologic Oncology Innovation Award in recognition for his role in the development of sentinel lymph node biopsy in gynecologic oncology patients and his lead investigator role in multiple institutional and national clinical trials.
Ate G.J. van der Zee, MD, PhD is Professor of Gynaecological Oncology and Vice President of the Board of Directors, University Medical Center Groningen, The Netherlands. He leads a world-wide consortium (GROINSS-V-II), which performs landmark clinical studies in vulvar cancer, and shared the SGO Innovation Award in 2017.
Robert L. Coleman, MD, FACOG, FACS is Chief Scientific Officer, US Oncology Research, The US Oncology Network, McKesson Specialty Health, The Woodlands, TX, USA, and formerly Professor and Ann Rife Cox Chair of the Department of Gynecologic Oncology and Reproductive Medicine at the University of Texas MD Anderson Cancer Center and Executive Director of Cancer Network Research.